Slider

Investing.com — In a recent note, Bank of America outlined 14 key lessons from 2024 that investors should keep in mind as they head into 2025, warning that market momentum…

Investing.com — The landscape of GLP-1 drugs, which are widely recognized for their efficacy in weight loss and diabetes management, is poised for a potential transformation in 2025, as per…

Investing.com — The U.S. housing market is expected to see mild improvements in 2025, but elevated mortgage rates and affordability challenges will continue to weigh on activity, according to a Bank…

Investing.com — In its report titled “2025 Global Real Estate Outlook,” RBC Capital Markets said it anticipates diverging paths for Canadian (CDN) and U.S. REITs in 2025, underpinned by valuation…

TOKYO (Reuters) – Honda (NYSE:HMC) and Nissan (OTC:NSANY) are considering producing vehicles in one another’s factories as part of their talks to deepen ties, news agency Kyodo reported on Saturday…

By Jody Godoy (Reuters) – Alphabet (NASDAQ:GOOGL)’s Google proposed on Friday a loosening of its agreements with Apple (NASDAQ:AAPL) and others to set Google as the default search engine on…

TORONTO (Reuters) – A U.S. judge ruled on Friday in favor of Meta (NASDAQ:META) Platform Inc’s WhatsApp in a lawsuit accusing Israel’s NSO Group of exploiting a bug in the…

By Raphael Satter and AJ Vicens WASHINGTON (Reuters) – Officials in the United States and Israel have denied reports their countries had signed off on the sale of Israeli spyware…

By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly (NYSE:LLY)’s weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to…

By David Shepardson WASHINGTON (Reuters) -The U.S. Commerce Department said on Friday it was finalizing an award of up to $4.745 billion to South Korea’s Samsung Electronics (KS:005930) and up…